The three-drug combination was hailed by researchers as a huge breakthrough and potentially transformative for those with a common form of breast cancer.
A study, published by The New England Journal of Medicine, revealed some 161 patients were given a three-drug therapy, which comprised two targeted drugs – palbociclib, a type of cancer growth blocker, and a new drug called inavolisib.
The treatment targets the growth of a cancer protein called PI3K protein.
The study included 325 patients from across 28 countries, more than half of whom had cancer that had spread to three or more organs, while more than 80 per cent had already had chemotherapy.
The 161 patients were given the medication alongside the hormone therapy fulvestrant as part of the combination.
The placebo group, which included 164 patients, were given a placebo plus palbociclib and fulvestrant.
Researchers found the three-drug therapy delayed disease progression by an average of 15 months compared with 7.3 months in the placebo group.
هذه القصة مأخوذة من طبعة October 31, 2024 من The Independent.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة October 31, 2024 من The Independent.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Is our anti-ageing obsession now totally out of hand?
With women opting for botox injections to keep their hands looking youthful, Ellie Muir examines new beauty standards
Reeves takes an extra £2bn in inheritance tax - for now
Inheritance tax (IHT) is an odd one; many worry about it but only a tiny minority ever end up paying it. After this Budget, the minority will grow and the bills they face will rise.
Manchester United's life is in Amorim's capable hands
The manager made a fading Portuguese side into champions. Lawrence Ostlere pinpoints the tactics that may save United
Did the Women's Equality Party achieve its ambition?
Leaders of the Women's Equality Party (WEP) propose to wind up their organisation. A statement issued by its executive committee, endorsed by co-founders Sandi Toksvig and Catherine Mayer, declares: \"The truth is, despite themphenomenal efforts of our team, tireless activists and brilliant members, we can no longer see a way to make this work. Everybody is struggling, particularly women.
New breast cancer therapy drug 'doubles survival time
A new drug therapy for aggressive advanced breast cancer could potentially double the amount of time patients live without the disease progressing, a trial has found.
Northern Rail reveals it is still communicating via fax
A Northern Rail official has admitted the operator still uses fax machines to communicate with its train crews in an excruciating exchange about the state of its services.
Abortion clinic protest ban watered down, activists say
Campaigners have hit out at the decision not to automatically ban silent prayer outside abortion clinics when new buffer zones are implemented today. Under the new measures, it will now be illegal to influence, harass or provoke those using or delivering abortion services within a 150-metre radius of the abortion provider. Those who infringe the new rules can be hit with an unlimited fine.
First UK case of potentially deadly mpox strain detected
The first UK case of a potentially deadly strain of the has been detected in London.
Key figures from day when long-held records tumbled
The first Budget by a Labour chancellor in 14 years, and the first to be delivered by a woman, also signalled some major historical milestones for tax and spending.
Sunak showed his anger in his last stand as Tory leader
The Budget reply was Rishi Sunak's last big gig in the House of Commons despite Keir Starmer's joke during Prime Minister's Questions that the Conservatives change leader so often, \"he may be back here\" soon. In those exchanges, Starmer and Sunak were all courtesy and best behaviour. Starmer paid tribute to his defeated opponent’s “decency”; Sunak was softly spoken and bipartisan.
